HIPAA and CLIA Compliance for Clinical Laboratories: Key Overlaps and Differences

Kevin Henry

HIPAA

Published Updated

8 minutes read
Share this article
HIPAA and CLIA Compliance for Clinical Laboratories: Key Overlaps and Differences

How do HIPAA and CLIA regulate clinical laboratories differently?

CLIA and HIPAA address different risks. The Clinical Laboratory Improvement Amendments (CLIA) focus on the accuracy and reliability of laboratory testing, while HIPAA governs the privacy and security of protected health information (PHI) and certain health care transactions.

CLIA requirements depend on the tests a laboratory performs and their complexity. HIPAA requirements depend on whether the laboratory is a covered entity or business associate. A CLIA certificate does not establish HIPAA compliance, and complying with HIPAA does not replace CLIA certification. CMS’s CLIA regulations and compliance resources and HHS’s HIPAA Security Rule overview describe these distinct responsibilities.

The laws also overlap in their effect on patient access. Federal rules allow patients or their authorized representatives to request completed laboratory reports directly from laboratories, subject to identity and authority verification.

Which laboratories and organizations must comply with CLIA and HIPAA?

In general, a facility or site that tests human specimens to assess health or diagnose, prevent, or treat disease must have an appropriate CLIA certificate before testing. This can include hospital and independent laboratories, physician-office laboratories, and sites performing point-of-care testing. The certificate must cover the level of testing performed.

Some activities or facilities may be excepted, including forensic testing and research testing that does not report patient-specific results for diagnosis, prevention, treatment, or individual health assessment. Specimen collection alone does not generally make a site a laboratory under CLIA. Review the specific circumstances and applicable state requirements; CMS’s CLIA overview describes common exceptions.

HIPAA applies to health plans, health care clearinghouses, and health care providers that conduct certain standard transactions electronically, such as electronic billing. A laboratory may be a covered entity if it meets that definition. A laboratory that handles PHI for a covered entity may also have duties as a business associate under its business associate agreement. Not every CLIA laboratory is automatically subject to HIPAA as a covered entity, so the organization’s activities and relationships matter. See HHS’s explanation of who must comply with the HIPAA Privacy Rule.

What CLIA certification, quality control, and proficiency testing requirements apply?

A laboratory must obtain the certificate type that matches the highest-complexity testing it performs. A CLIA certificate of waiver (CoW) covers only tests categorized as waived; it does not authorize a laboratory to perform moderate- or high-complexity tests. Waived laboratories must follow the test manufacturer’s instructions, including applicable instructions for quality control and test performance. CMS’s certificate application guidance explains the certificate categories and waived-testing requirements.

Nonwaived testing is subject to more extensive CLIA quality-system requirements. Depending on the test and certificate, these include requirements for laboratory personnel, quality control, quality assessment, and records. Laboratories should use the requirements applicable to each test rather than assume that one general laboratory quality control procedure covers every method. The detailed federal requirements are in 42 CFR Part 493.

CLIA proficiency testing (PT) evaluates laboratory performance using samples from an approved program. Laboratories performing nonwaived tests for analytes on the regulated list generally must participate in an approved PT program. PT samples must be tested like patient specimens and cannot be referred to another laboratory for analysis. PT is not a substitute for routine quality control. Waived testing does not generally require PT under CLIA, though laboratories may choose to participate. See CMS’s proficiency testing guidance.

What HIPAA safeguards and breach notification duties apply to laboratory data?

When HIPAA applies, the Privacy Rule governs permitted uses and disclosures of PHI, including laboratory reports. The Security Rule requires reasonable and appropriate administrative, physical, and technical safeguards for electronic protected health information safeguards (ePHI). Laboratories must assess risks, control access, protect systems and devices, and maintain policies and documentation suited to their size and operations. HIPAA does not prescribe one universal technology or security setup. HHS’s Security Rule summary explains these standards.

A laboratory that uses a service provider to create, receive, maintain, or transmit PHI on its behalf may need a business associate agreement and must address the provider’s security responsibilities. The laboratory should also have procedures to detect, investigate, and respond to incidents involving PHI.

A breach of unsecured protected health information generally triggers notification duties unless an exception applies or the organization demonstrates a low probability that the PHI was compromised through the required risk assessment. Covered entities generally must notify affected individuals without unreasonable delay and no later than 60 calendar days after discovery. Breaches affecting 500 or more individuals also require timely notice to HHS and, in certain cases, the media; breaches affecting fewer than 500 individuals must be reported to HHS within the annual reporting timeframe. Business associates must notify the covered entity as required by HIPAA and their agreement. See HHS’s Breach Notification Rule guidance.

Ready to simplify HIPAA compliance?

Join thousands of organizations that trust Accountable to manage their compliance needs.

Get Started Free Today

How can patients access laboratory reports and other records?

A patient may submit a laboratory patient access request to a HIPAA-covered laboratory for PHI about the patient in the laboratory’s HIPAA designated record set. This may include completed test reports and, when maintained in the designated record set, underlying data generated as part of testing, test orders, ordering-provider information, and billing or insurance information. A laboratory does not have to provide a report that is not yet complete, but other accessible records may already exist.

A covered laboratory generally must act on an access request within 30 calendar days. If it cannot meet that deadline, it may take one extension of up to 30 additional days, provided it gives the patient written notice within the original period that explains the reason for the delay and the expected completion date. The laboratory must provide access to the PHI it maintains in the designated record set, subject to limited exceptions. HHS’s Right to Access guidance for laboratories explains how these rules apply to completed reports and underlying data.

CLIA rules also permit patients, their personal representatives, or people designated by patients to request copies of completed laboratory reports. This access rule does not require the laboratory to interpret the results. See HHS’s overview of patient access to laboratory test reports.

How should laboratories authenticate patients before releasing results?

Before disclosing PHI, a covered laboratory must use reasonable procedures to verify the identity and authority of a requester if that information is not already known. Identity answers who is making the request; authority establishes whether that person may access the patient’s information, for example as the patient, a personal representative, or a person the patient has designated.

HIPAA does not require one specific verification method, such as always demanding a government-issued photo ID. A laboratory may use reasonable procedures suited to how the request is submitted, such as matching information against its records or using a secure portal. Its process should protect confidentiality without creating an unreasonable barrier or delay to access. The verification standard is set out in 45 CFR § 164.514(h); HHS also describes the flexibility of identity and authority checks in its guidance on electronic access.

What are the limits of laboratory duties to interpret test results?

HIPAA gives patients a right to access qualifying records; it does not require a laboratory to interpret results or explain what they mean for a patient’s diagnosis or treatment. A laboratory may direct clinical questions to the ordering or treating provider, who can consider the results alongside the patient’s history and other findings.

Laboratories may choose to provide educational or explanatory material, but that is different from the access obligation itself. HHS confirms that a covered laboratory must provide access to completed reports and other accessible records in the designated record set, but is not required by HIPAA to interpret them. See HHS’s laboratory access FAQs.

In summary, CLIA governs laboratory testing quality and certification, while HIPAA governs privacy, security, and access when it applies. Laboratories should identify their CLIA certificate and test-specific quality duties, determine their HIPAA status, protect patient data, and maintain a reliable process for handling access requests.

FAQs

Does CLIA apply to every facility that tests human specimens?

No. CLIA generally applies when a facility tests human specimens to assess health or diagnose, prevent, or treat disease, but exceptions exist. Examples include certain forensic testing and research testing that does not report patient-specific results for clinical or individual health-assessment purposes. Facilities that only collect or prepare specimens may also fall outside the definition of a laboratory. Check the activity and applicable exceptions against CMS guidance and the regulations.

How long does a HIPAA-covered laboratory have to respond to a patient access request?

Generally, the laboratory must act within 30 calendar days after receiving the request. It may take one extension of up to 30 additional calendar days if it gives the patient written notice within the original 30-day period explaining the delay and the expected response date. See HHS’s Right to Access guidance.

Can patients request underlying laboratory test data under HIPAA?

Yes, when the information is PHI about the patient in the covered laboratory’s designated record set. Depending on what the laboratory maintains, that may include underlying data generated as part of testing as well as reports, orders, and other related records. See HHS’s guidance on laboratory access and underlying data.

Does HIPAA require laboratories to interpret test results for patients?

No. HIPAA requires covered laboratories to provide access to qualifying records, not to interpret results. Patients with questions about clinical meaning may be referred to the ordering or treating provider. A laboratory may choose to provide educational material, but HIPAA does not require it to do so.

Share this article

Ready to simplify HIPAA compliance?

Join thousands of organizations that trust Accountable to manage their compliance needs.

Get Started Free Today

Related Articles